BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) a clinical-stage immunotherapy company driven to fight cancer and improve patients’ lives, announced that it has received approval...

To read the full story on AllPennyStocks.com, click here.

BriaCell Therapeutics (TSX:BCT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse BriaCell Therapeutics
BriaCell Therapeutics (TSX:BCT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse BriaCell Therapeutics